News of the index components FTSE 100

Index

UKX

GB0001383545

Market Closed - Great Britain 16:35:30 19/06/2024 BST			5-day change	1st Jan Change
8,205 ^PTS	+0.17%		-0.13%	+6.10%

06-19	Stocks mixed ahead of Bank of England decision	AN
06-19	London's FTSE 100 gains after CPI shows in-line inflation, copper prices boost	RE

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Astrazeneca Says Imfinzi Approved In U.S. For Endometrial Cancer AZN	06-17	RE
AstraZeneca : Imfinzi approved in the US for endometrial cancer AZN	06-17	PU
AstraZeneca plc Approves Imfinzi Plus Chemotherapy in the US for Completes Deficiency Advanced or Recurrent Endometrial Cancer AZN	06-17	CI
Kingfisher plc Announces Chief Financial Officer Changes KGF	06-17	CI
Ex-Melrose CEO plots London listing for new vehicle — Sky News MRO	06-17	AN
AstraZeneca's Calquence Combo Extends Progression-free Survival in Mantle Cell Lymphoma Study AZN	06-17	MT
Prudential : appoints Zoe Hibbert as Chief of Corporate Affairs PRU	06-17	PU
StanChart Buys Back 1 Million Shares STAN	06-17	MT
HSBC Buys Back 8.5 Million Shares in UK, Hong Kong HSBA	06-17	MT
Prudential Appoints Grace Park as Its Chief Data, Analytics & AI Officer PRU	06-16	CI
Hikma Pharmaceuticals PLC agreed to acquire Finished Dosage Form Business and Assets of Xellia Pharmaceuticals for approximately $190 million. HIK	06-16	CI
AstraZeneca Announces CALQUENCE (Acalabrutinib) Plus Chemoimmunotherapy Reduced the Risk of Disease Progression or Death by 27% Vs. Standard of Care in Patients with Untreated Mantle Cell Lymphoma in Echo Phase III Trial AZN	06-16	CI
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial AZN	06-16	BU
AstraZeneca : Calquence plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial AZN	06-16	PU
Serbia set to give green light to Rio Tinto lithium mine, FT reports RIO	06-16	RE
Acuity RM loss widens; names new finance director LLOY	06-14	AN
NY Fed data shows neutral rate holding steady at low level HLMA	06-14	RE
BAE Systems Chair Ayotte to Resign to Run for New Hampshire Governor BA.	06-14	DJ
Phoenix Group to accept USD500 million notes tendered PHNX	06-14	AN
BAE : announces leadership transition on Board of Directors BA.	06-14	PU
CMS: BP p.l.c.: Release of a capital market information BP.	06-14	EQ
Azerbaijan says January to May oil exports via BTC pipeline down 3.6% y/y BP.	06-14	RE
Workers at Shell's Scotford facility in Canada move to set up strike vote SHEL	06-14	RE
TESCO : A strong start to FY24/25! TSCO	06-14
Transaction in Own Shares SHEL	06-14	GL
UK Stocks Slump Amid Widespread Sell-off in Europe TSCO	06-14	MT
Legal & General : Analyst Q&A Transcript LGEN	06-14	PU
Norway-listed Kyoto Group Agree to Investment, Takeover Deal with Glentra SPX	06-14	MT
Tesco chairman says 'no difficulty' defending CEO's $13 mln pay package TSCO	06-14	RE
Tesco : Resolutions of AGM TSCO	06-14	PU
Q1 Trading Statement 2024/25: Audiocast transcript TSCO	06-14	PU
HSBC : CLOSING ANNOUNCEMENT ISSUANCE OF PERPETUAL SUBORDINATED CONTINGENT CONVERTIBLE SECURITIES HSBA	06-14	PU
Russia boosts oil revenues as shipping and trading network grows LLOY	06-14	RE
Goldman Sachs Keeps Burberry at Neutral, Lowers PT BRBY	06-14	MT
Berenberg Lifts Halma PT, Keeps Hold Rating HLMA	06-14	MT
Deutsche Bank Lowers B&M European Value Retail PT, Affirms at Buy BME	06-14	MT
Barclays Lifts Halma PT, Maintains Overweight Rating HLMA	06-14	MT
Bank of America Upgrades Legal & General Group to Buy from Neutral, Trims PT LGEN	06-14	MT
Tesco CEO's $13 mln pay package 'competitive' with global market, says chairman TSCO	06-14	RE
TESCO CHAIRMAN COMMENTING ON CEO KEN MURPHY'S 10 MLN STG PAY PAC… TSCO	06-14	RE